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Cytokines are messengers of immune system. They are
small secreted proteins that mediate and regulate the
immune system, inflammation and hematopoiesis. Recent
studies have revealed important roles played by the cyto-
kines in adjuvants as therapeutic targets and in cancer
therapy. In this paper, an attempt has been made to
predict this important class of proteins and classify
further them into families and subfamilies. A PSI-
BLAST+Support Vector Machine-based hybrid approach
is adopted to develop the prediction methods. CytoPred is
capable of predicting cytokines with an accuracy of
98.29%. The overall accuracy of classification of cytokines
into four families and further classification into seven
subfamilies is 99.77 and 97.24%, respectively. It has been
shown by comparison that CytoPred performs better
than the already existing CTKPred. A user-friendly
server CytoPred has been developed and available at
http://www.imtech.res.in/raghava/cytopred.
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Introduction
Cytokines are hormone-like proteins that enable immune
cells to communicate, and play an integral role in the
initiation, perpetuation and subsequent down-regulation of
the immune response. They are small secreted proteins that
possess pleiotropic functions and mediate systemic and local
biological actions. Studies have revealed that cytokines have
important role in the pathogenesis and progression of dis-
eases like rheumatoid arthritis (Feldmann et al., 1996),
Chron’s disease (Pizarro and Cominelli, 2007), and inflam-
mation, and hold promise to act as therapeutic targets.
Various cytokines and growth factors are believed to orches-
trate cellular behavior in a healing cornea (Saika, 2007) and
also play a role in injury-induced neural damage and repair
(Allan and Rothwell, 2001; Schroeter and Jander, 2005).
Cytokines are used in cytokine therapies to help immune
system to recognize and destroy those cells that are cancerous
(Tagawa, 2000; Kalaaji, 2007; Weiss et al., 2007) and in
therapies that are routinely used by people living with HIV
(Kim et al., 1999). Therefore, they have applications in the
treatment of hematologic malignancies and immunogenic
tumors. Since cytokines were also found to be the effector
molecules for many adjuvant effects (Afonso et al., 1994;
Staats and Enni, 1999; Lori et al., 2006; Eaton, 2007;
Pardoll, 1995), there has been an effort to build the optimal
vaccine adjuvant effect one cytokine at a time.
Keeping in mind such diverse roles played by the cyto-
kines, identification of these cytokine would enable us to
dissect the complex reactions and to advance our knowledge
on how an immune system is operated. A large amount of
sequence data are piling up with the completion of ongoing
genome-sequencing projects, but the functional class of
several proteins still remains unclear. Thus, computer-aided
prediction of cytokines from a large amount of sequence
data whose function is still largely unknown would be very
fruitful for biologists as the experimental determination of
the functions would be a laborious and time-consuming job.
Earlier an attempt has been made where a Support Vector
Machine (SVM)-based method has been developed for the
prediction and classification of cytokine superfamily (Huang
et al., 2005). In this paper, an attempt has been made to
achieve higher prediction accuracy for the cytokine predic-
tion and classification. A hybrid approach of PSI-BLAST
and SVM was adopted in order to predict the cytokines and
classify further them into families and subfamilies.
Methods
Cytokine prediction
For cytokine prediction, the dataset contained a total of 1110
sequences, having 437 positive and 673 negative examples
(randomly selected from the SCOP version 1.37 PDB90
domain data). This dataset was the same as used by the
method CTKPred and is downloaded from http://cytokine.
medic.kumamoto-u.ac.jp/. No two examples in the dataset
are .90% similar, i.e. the dataset is non-redundant. The pre-
diction for any query protein was done at first by similarity
search-based module, the PSI-BLAST, and if in case it failed
to generate any hits, the prediction was done based on SVM.
For SVM-based predictions, dipeptide composition of the
sequences was taken as an input. In this study, a cut-off
value was chosen where the sensitivity and specificity were
nearly equal or the difference between them is the least, for
evaluating and developing SVM-based methods.
Evaluation of the cytokine prediction was done using
7-fold cross validation technique. The data were randomly
divided into seven sets, each set containing almost equal
number of examples. The method was trained on six sets and
tested on the remaining one set. This was repeated seven
times, so that each set was used once as test set. The method
achieved an accuracy of 98.29% at cut-off where the sensi-
tivity and specificity were nearly equal. The performance of
the hybrid method for cytokine prediction is given in
Table I.
Cytokine classification
Family classification The dataset contains sequences form
seven major families of cytokines containing about 83 FGF/
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HBGF family sequences, 22 IL-6 family sequences, 12 LIF/
OSM family sequences, 10 MDK/PTN family sequences, 24
NGF family sequences, 190 TGF-B family sequences and 96
TNF family sequences. Therefore, a prediction method to
classify the cytokines into families was also developed. As
the number of sequences in families LIF/OSM, DK/PTN and
NGF were not enough, these were clubbed together to form a
single class called ‘joint class’. Thus, the method was devel-
oped to predict four families of cytokines instead of seven.
For family classification, the dataset consisted of 437 cyto-
kine sequences only. As it is multi-class prediction problem,
we developed a series of classifiers to handle the problem. N
SVMs were constructed for N-class classification. For cyto-
kine family classification, the number of classes was equal to
4. The ith SVM was trained with all the samples of ith class
labeled positive and all other samples labeled negative. An
unknown example was classified into the class that corre-
sponds to the SVM with the highest output score. The results
for the family prediction are given in Table II.
Subfamily classification Among all the families, TGF-b was
the only family having sufficient number of sequences that
could be used for training and testing in order to develop a
prediction method. So, we chose to develop a method that
could also predict the subfamily of cytokines if they
belonged to the TGF-b family. As the TGF-b family can be
further divided into six subfamilies including bone morpho-
genetic protein (BMP), growth differentiation factor (GDF),
glial-derived neurotrophic factor (GDNF), inhibin (INHA/
INHB), transforming growth factor-b (TGFb) and others,
again a multi-class classification was done as described for
cytokine family prediction. The evaluation was done by
2-fold cross validation. The results for subfamily prediction
are given in Table III.
Evaluation parameters
The evaluation of performance of the method was done by
calculating the sensitivity, specificity, accuracy and the MCC
of the prediction. The formulae for calculating these par-
ameters are as follows:
Sensitivity ¼ TP
TP+FN
 100
Specificity ¼ TN
TN+FP
 100
Accuracy ¼ TP+TN
TP+TN+FP+FN
 100
MCC ¼ TP  TN  FP  FNffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi½ðTP+FNÞðTN+FPÞðTP+FPÞðTN+FNÞp :
Results and discussions
The performance of the method for predicting the cytokines,
based on amino acid composition, dipeptide composition,
CytoPred (based on Hybrid approach), is compiled and pre-
sented in Table I. Among these, the performance of the
amino acid composition-based method was the poorest.
Composition-based method gave an accuracy of 94.50% and
an MCC of 0.88. The performance of dipeptide composition-
based method performed better than simple composition-
based method (with accuracy and MCC), but was further out-
performed by the Hybrid approach-based method. The
hybrid approach-based method performed best and achieved
accuracy 98.29% and MCC 0.91. The performance is also
compared with that of an already existing method, CTKPred
(Table I). The hybrid approach-based method outshines the
performance of CTKPred too.
An attempt was made to further classify the cytokines into
families and subfamilies. The classification of cytokine
family was done at first by using the dipeptide composition
alone (Table II). The dipeptide-based cytokine family classi-
fication achieved an overall accuracy of 96.34% and an
average MCC of 0.95. The classification was done by using
the hybrid approach. The performance of the hybrid
approach is compared one-to-one with that of the method
CTKPred (Table II). The overall accuracy achieved by
hybrid module was 99.77% and the average MCC was 0.99,
which is better than that achieved by CTKPred.
Similar trend was followed in further classification of
TGF-b family into subfamilies. The detailed results of the
Table I. Comparison of performance of various methods for predicting
cytokines
Method Sensitivity
(%)
Specificity
(%)
Accuracy
(%)
MCC
SVM (aa comp.) 91.99 96.14 94.50 0.88
SVM (dip. comp.) 92.91 97.47 95.68 0.91
Hybrid
(PSI-BLAST+SVM)
98.40 98.22 98.29 0.96
CTKPred 92.5 97.2 95.3 0.90
aa comp., amino acid composition; Dip. Comp., dipeptide composition.
Table II. Performance of various methods (SVM alone, CytoPred and CTKPred for Cytokine family classification)
Family Sensitivity (%) Specificity (%) Accuracy (%) MCC
SVM
(Dip.)
CytoPred
(Hybrid)
CTKPred SVM
(Dip.)
CytoPred
(Hybrid)
CTKPred SVM
(Dip.)
CytoPred
(Hybrid)
CTKPred SVM
(Dip.)
CytoPred
(Hybrid)
CTKPred
FGF/HBGF 93.98 100 92.7 99.44 100 98.6 98.40 100 97.5 0.95 1.00 0.92
TGF-b 97.37 100 91.0 97.17 99.73 99.7 97.25 99.77 98.4 0.94 0.99 0.94
TNF 96.68 100 97.4 100.00 99.60 94.7 99.31 99.77 95.8 0.98 1.00 0.92
Joint class 95.59 97.92 94.0 98.10 100 98.8 97.71 99.54 97.7 0.92 0.99 0.94
Dip., dipeptide composition.
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performance of the dipeptide composition-based module
alone and the one-to-one comparison of hybrid model
against CTKPred are given in Table III. The overall accuracy
achieved by CytoPred in subfamily classification was
97.24% and the average MCC achieved was 0.92, which
were again better than that achieved by CTKPred.
Table III. Performances of various methods (SVM alone, CytoPred and CTKPred for Cytokine sub-family classification)
Subfamily Sensitivity (%) Specificity (%) Accuracy (%) MCC
SVM
(Dip.)
CytoPred
(Hybrid)
CTKPred SVM
(Dip.)
CytoPred
(Hybrid)
CTKPred SVM
(Dip.)
CytoPred
(Hybrid)
CTKPred SVM
(Dip.)
CytoPred
(Hybrid)
CTKPred
BMP 80.43 97.83 87.5 92.36 95.83 85.5 89.47 96.32 86 0.72 0.91 0.67
GDF 84.38 96.88 82.4 96.84 98.73 95.2 94.74 98.42 93 0.81 0.94 0.76
GDNF 86.67 93.33 75 98.86 100.00 100 97.89 99.47 98 0.86 0.94 0.86
INH 92.86 100.00 46.7 98.77 98.77 100 97.89 98.95 92 0.92 0.96 0.65
TGF-b 91.30 91.30 100.00 100.00 98.80 98.9 98.95 97.89 99 0.95 0.90 0.96
Others 71.74 82.61 66.7 90.97 99.31 89.5 86.32 95.26 84 0.63 0.87 0.56
Dip., dipeptide composition.
Fig. 1. A snapshot of CytoPred server home page.
Fig. 2. Submission page of CytoPred.
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CytoPred can predict as well as classify a cytokine
protein with high accuracy as well as with high sensitivity
and specificity. Thus, the PSI-BLAST+SVM-based method
is better than SVM alone in predicting and classifying the
query sequences to cytokines. We hope that our method
would be of great help in order to annotate the proteins
and would aid the experimental validation, in turn, saving
time and labor.
Web server
All the modules constructed in this study have been
implemented on the World Wide Web as a dynamic web
server ‘CytoPred’ (Fig. 1), which is available at http://www.
imtech.res.in/raghava/cytopred. All the CGI scripts of the
method were written in PERL5.0 and the interface was
designed using HTML. The SVM and PSI-BLAST were
implemented by obtaining SVM_light from http://www.cs.
cornell.edu/People/tj/svm_light/ and PSI-BLAST from http://
www.ncbi.nlm.nih.gov/blast/. It is a user-friendly web server
which allows users to submit their protein sequence by
typing or pasting in box or by using the file upload facility
(Fig. 2). The server provides an option to select the predic-
tion approach. In the case of default prediction, the server
uses the hybrid module for prediction. However, if the user
wants to make predictions for multiple sequences at a time,
he is suggested to use the SVM-based model. The server pre-
sents the results of comprehensive analysis in user-friendly
format (Fig. 3).
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Fig. 3. The result generated by server CytoPred.
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